Cargando…
Oral Administration of Porphyromonas gingivalis, a Major Pathogen of Chronic Periodontitis, Promotes Resistance to Paclitaxel in Mouse Xenografts of Oral Squamous Cell Carcinoma
Chemotherapy is not a first-line therapy for oral squamous cell carcinoma (OSCC), which is the most common type of oral cancer, because most OSCC shows resistance to chemotherapeutic reagents. Inflammatory signals are suggested to be associated with chemoresistance as well as carcinogenesis in many...
Autores principales: | Song, Jae Min, Woo, Bok Hee, Lee, Ji Hye, Yoon, Sanggyeong, Cho, Youngseuk, Kim, Yong-Deok, Park, Hae Ryoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566430/ https://www.ncbi.nlm.nih.gov/pubmed/31117164 http://dx.doi.org/10.3390/ijms20102494 |
Ejemplares similares
-
Serum Levels of Interleukin-6 and Titers of Antibodies against Porphyromonas gingivalis Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
por: Park, Dae-Gun, et al.
Publicado: (2019) -
Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential
por: Woo, Bok Hee, et al.
Publicado: (2017) -
Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease
por: Kobayashi, R., et al.
Publicado: (2017) -
Acetylshikonin suppresses invasion of Porphyromonas gingivalis-infected YD10B oral cancer cells by modulating the interleukin-8/matrix metalloproteinase axis
por: Cho, Bong-Hae, et al.
Publicado: (2018) -
Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome
por: Kato, Tamotsu, et al.
Publicado: (2018)